Company research / PETV

PetVivo Holdings, Inc. (PETV)

CIK 0001512922 · OTC · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated NV
  • Fiscal year ends Mar 31

For the year ended 2026-03-31, PetVivo Holdings, Inc. reported revenue of $1.14M. Revenue grew 0.8% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $1.18M.

Key ratios (year ended 2026-03-31)

66.1%
Gross margin
-793.9%
Operating margin
-917.4%
Net margin
-476.2%
Return on year-end equity
0.8%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-09-22

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30
2026-03-312025-03-312024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
Revenue$1.18M$1.14M$1.13M$968.7K$917.2K$115.6K$12.6K$3.6Kn/a$1.5K$7.1K
Cost of Revenue$390.3K$386.9K$137.7K$101.8K$221.0K$201.2K$10.7K$19.7K$77.9Kn/an/a
Gross Profit$791.3K$754.8K$994.9K$866.9K$696.1K-$85.6K$1.9K-$16.1K-$77.9K$1.5K$7.1K
R&D Expense$1.31M$1.42M$1.58M$1.40M$996.4K$474.9K$98.2K$12.7K$201.0K$118.9K$167.9K
Operating Income-$8.83M-$9.06M-$8.06M-$10.62M-$8.73M-$5.06M-$1.96M-$2.02M-$4.67M-$2.29M-$16.39M
Depreciation & Amortization$528.2K$511.5K$174.6K$126.8K$114.4K$65.2K$86.7K$559.5K$646.9K$643.4K$746.8K
EBITDA-$8.30M-$8.55M-$7.88M-$10.49M-$8.62M-$4.99M-$1.87M-$1.46M-$4.03M-$1.64M-$15.64M
Net Income-$9.78M-$10.47M-$8.40M-$10.96M-$8.72M-$5.01M-$3.52M-$2.08M-$4.76M-$2.34M-$16.52M
EPS (Diluted)n/a-$0.38-$0.41-$0.78-$0.85n/an/an/an/an/an/a
Total Assets$2.67M$3.58M$9.34M$3.12M$2.44M$7.43M$835.2K$522.5K$691.1K$1.57M$1.90M
Total Liabilities$1.31M$1.38M$5.12M$2.43M$1.71M$1.44M$1.73M$1.56M$1.54Mn/an/a
Shareholders' Equity$1.36M$2.20M$4.22M$686.0K$725.0K$5.99M-$897.0K-$1.04M-$844.8K$136.6K-$13.48M
Cash & Equivalentsn/an/an/a$87.4K$475.3K$6.11M$23.6K$888$6.5K$237.3K$25.4K
Operating Cash Flow-$5.44M-$6.11M-$5.32M-$7.42M-$6.79M-$4.17M-$767.2K-$498.1K-$736.4K-$575.2K-$143.0K
Capital Expendituresn/a$7.7K$63.4K$309.1K$423.9K$154.0K$140.7K$32.8K$27.1K$19.2Kn/a
Free Cash Flown/a-$6.12M-$5.39M-$7.73M-$7.22M-$4.33M-$907.9K-$530.9K-$763.6K-$594.4Kn/a
Shares Outstanding37.59M35.85M24.18M17.06M10.95M9.99M6.80M5.73M19.87M18.28M9.32M
Weighted Average Diluted Sharesn/a30.15M20.49M13.97M10.22Mn/an/an/an/an/an/a
EPS (Basic)n/a-$0.38-$0.41-$0.78-$0.85-$0.57-$0.57n/an/an/an/a